Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$39.66 - $51.75 $1.39 Million - $1.82 Million
-35,100 Reduced 43.01%
46,500 $2.41 Million
Q2 2024

Aug 01, 2024

SELL
$40.25 - $52.99 $410,550 - $540,498
-10,200 Reduced 11.11%
81,600 $3.39 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $1.32 Million - $1.5 Million
-27,500 Reduced 23.05%
91,800 $4.98 Million
Q4 2023

Feb 01, 2024

BUY
$48.48 - $57.85 $3.27 Million - $3.9 Million
67,400 Added 129.87%
119,300 $6.12 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $1.63 Million - $1.82 Million
-28,100 Reduced 35.13%
51,900 $3.01 Million
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $210,243 - $233,441
3,300 Added 4.3%
80,000 $5.12 Million
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $2.88 Million - $3.26 Million
43,800 Added 133.13%
76,700 $5.32 Million
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $2.25 Million - $2.66 Million
32,800 Added 32800.0%
32,900 $2.37 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $13 - $7,684
100 New
100 $7,000
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $2.23 Million - $2.47 Million
-50,000 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $2.4 Million - $2.87 Million
-53,300 Reduced 51.6%
50,000 $2.39 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $4.03 Million - $5.23 Million
-82,700 Reduced 44.46%
103,300 $5.37 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $1.55 Million - $1.75 Million
-28,100 Reduced 13.12%
186,000 $11.5 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $5.46 Million - $6.81 Million
108,100 Added 101.98%
214,100 $11.8 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $1.91 Million - $2.19 Million
-31,800 Reduced 23.08%
106,000 $6.7 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $29,970 - $32,674
500 Added 0.36%
137,800 $8.44 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $1.34 Million - $1.54 Million
24,200 Added 21.4%
137,300 $8.75 Million
Q2 2017

Aug 14, 2017

BUY
N/A
113,100
113,100 $6.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.